Providers believe the digital modality could ultimately provide a more accurate cancer diagnosis compared to conventional PET, authors reported in the Journal of Nuclear Medicine.

The U.S Food and Drug Administration gave the go-ahead for two additional molybdenum-99 filling lines at the company's Columbia, Missouri, facility.

Idaho-based International Isotopes has received U.S. Food and Drug Administration approval for its radioactive therapeutic agent used to treat thyroid cancers.

Randall Batemen, MD, principal investigator of the research and a neurologist at Washington University in St. Louis, told the New York Times the results were "really crushing."

The National Institute on Aging awarded Wake Forest School of Medicine a five-year grant to examine if a novel PET tracer can help researchers tackle the disease.

Initial results were so successful that the material has been fast-tracked by the FDA in an effort to test its accuracy in human clinical trials.

University of Texas at Dallas researchers applied their novel method to organic radical contrast agents with encouraging conclusions.

A new special report published in Radiology includes two new case studies of individuals infected with the illness, and details how experts can harness CT to help diagnose 2019-nCoV.